Prior SARS-CoV-2 Infection and COVID-19 Vaccine Effectiveness against Outpatient Illness during Widespread Circulation of SARS-CoV-2 Omicron Variant, US Flu VE Network
Sara Y. Tartof, Fagen Xie, Ruchi Yadav, Karen J. Wernli, View ORCID ProfileEmily T. Martin, Edward A. Belongia, Manjusha Gaglani, View ORCID ProfileRichard K. Zimmerman, H. Keipp Talbot, View ORCID ProfileNatalie Thornburg, Brendan Flannery, View ORCID ProfileJessie R. Chung, US Flu VE Network Investigators
doi: https://doi.org/10.1101/2023.01.10.23284397
Sara Y. Tartof
1Kaiser Permanente Southern California, Department of Research & Evaluation
2Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA USA
Fagen Xie
1Kaiser Permanente Southern California, Department of Research & Evaluation
Ruchi Yadav
3Centers for Disease Control and Prevention, Atlanta, GA, USA
Karen J. Wernli
2Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA USA
4Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA
Emily T. Martin
5University of Michigan School of Public Health, Ann Arbor, MI, USA
Edward A. Belongia
6Marshfield Clinic Research Institute, Marshfield, WI, USA
Manjusha Gaglani
7Baylor Scott & White Health, Temple, TX, USA
8Texas A&M University College of Medicine, Temple, TX, USA
Richard K. Zimmerman
9University of Pittsburgh, Pittsburgh, PA, USA
H. Keipp Talbot
10Vanderbilt University Medical Center, Nashville, TN, USA
Natalie Thornburg
3Centers for Disease Control and Prevention, Atlanta, GA, USA
Brendan Flannery
3Centers for Disease Control and Prevention, Atlanta, GA, USA
Jessie R. Chung
11Influenza Division, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop 24/7, Atlanta, Georgia, 30329
Article usage
Posted January 11, 2023.
Prior SARS-CoV-2 Infection and COVID-19 Vaccine Effectiveness against Outpatient Illness during Widespread Circulation of SARS-CoV-2 Omicron Variant, US Flu VE Network
Sara Y. Tartof, Fagen Xie, Ruchi Yadav, Karen J. Wernli, Emily T. Martin, Edward A. Belongia, Manjusha Gaglani, Richard K. Zimmerman, H. Keipp Talbot, Natalie Thornburg, Brendan Flannery, Jessie R. Chung, US Flu VE Network Investigators
medRxiv 2023.01.10.23284397; doi: https://doi.org/10.1101/2023.01.10.23284397
Prior SARS-CoV-2 Infection and COVID-19 Vaccine Effectiveness against Outpatient Illness during Widespread Circulation of SARS-CoV-2 Omicron Variant, US Flu VE Network
Sara Y. Tartof, Fagen Xie, Ruchi Yadav, Karen J. Wernli, Emily T. Martin, Edward A. Belongia, Manjusha Gaglani, Richard K. Zimmerman, H. Keipp Talbot, Natalie Thornburg, Brendan Flannery, Jessie R. Chung, US Flu VE Network Investigators
medRxiv 2023.01.10.23284397; doi: https://doi.org/10.1101/2023.01.10.23284397
Subject Area
Subject Areas
- Addiction Medicine (405)
- Allergy and Immunology (714)
- Anesthesia (209)
- Cardiovascular Medicine (2989)
- Dermatology (254)
- Emergency Medicine (447)
- Epidemiology (12852)
- Forensic Medicine (12)
- Gastroenterology (839)
- Genetic and Genomic Medicine (4656)
- Geriatric Medicine (428)
- Health Economics (735)
- Health Informatics (2960)
- Health Policy (1076)
- Hematology (394)
- HIV/AIDS (939)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (478)
- Neurology (4442)
- Nursing (239)
- Nutrition (653)
- Oncology (2310)
- Ophthalmology (656)
- Orthopedics (260)
- Otolaryngology (328)
- Pain Medicine (286)
- Palliative Medicine (85)
- Pathology (504)
- Pediatrics (1205)
- Primary Care Research (506)
- Public and Global Health (7041)
- Radiology and Imaging (1560)
- Respiratory Medicine (927)
- Rheumatology (447)
- Sports Medicine (387)
- Surgery (495)
- Toxicology (60)
- Transplantation (213)
- Urology (186)